(Q34987435)

5 August 2017

1 reference

title

Critical review on non-myeloablative stem cell transplantation (NST). (English)

1 reference

5 August 2017

Anagnostopoulos A

1

1 reference

5 August 2017

Giralt S

series ordinal

2

1 reference

5 August 2017

publication date

1 November 2002

1 reference

Critical Reviews in Oncology Hematology

5 August 2017

published in

1 reference

5 August 2017

volume

44

1 reference

5 August 2017

issue

2

1 reference

5 August 2017

page(s)

175-190

1 reference

Bone marrow transplantation

5 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900226-8

7 January 2021

How does bone-marrow transplantation cure leukaemia?

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900226-8

7 January 2021

Treatment of murine leukaemia with X rays and homologous bone marrow; preliminary communication.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900226-8

7 January 2021

Antileukemic effect of chronic graft-versus-host disease: contribution to improved survival after allogeneic marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900226-8

7 January 2021

Bone marrow transplantation for chronic myelogenous leukemia in chronic phase. Increased risk for relapse associated with T-cell depletion.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900226-8

7 January 2021

Long-term survival of skin allografts in mice treated with fractionated total lymphoid irradiation

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900226-8

7 January 2021

Regression of Metastatic Renal-Cell Carcinoma after Nonmyeloablative Allogeneic Peripheral-Blood Stem-Cell Transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900226-8

7 January 2021

Clinical applications of mixed chimerism

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900226-8

7 January 2021

Mixed chimerism: preclinical studies and clinical applications

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900226-8

7 January 2021

Fludarabine and arabinosylcytosine therapy of refractory and relapsed acute myelogenous leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900226-8

7 January 2021

Fludarabine potentiates metabolism of cytarabine in patients with acute myelogenous leukemia during therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900226-8

7 January 2021

Metabolism and action of purine nucleoside analogs

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900226-8

7 January 2021

Mixed hematopoietic chimerism after marrow allografts. Transplantation in the ambulatory care setting

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900226-8

7 January 2021

Melphalan and purine analog-containing preparative regimens: reduced-intensity conditioning for patients with hematologic malignancies undergoing allogeneic progenitor cell transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900226-8

7 January 2021

Allogeneic bone marrow transplantation for poor-prognosis lymphoma: response, toxicity and survival depend on disease histology.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900226-8

7 January 2021

Transfusion-associated graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900226-8

7 January 2021

Graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900226-8

7 January 2021

Factors associated with graft rejection after HLA-identical marrow transplantation for aplastic anaemia

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900226-8

7 January 2021

10.1016/S1040-8428(01)00226-8

Identifiers

DOI

1 reference

5 August 2017

1 reference